News

No. Title Writer Date Inquiry
22 A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders.
관리자 23.05.19 Inquiry : 2,337
관리자 23.05.19 2,337
21 Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury
관리자 23.01.17 Inquiry : 2,523
관리자 23.01.17 2,523
20 3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation
관리자 23.01.17 Inquiry : 2,290
관리자 23.01.17 2,290
19 Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis.
관리자 23.01.17 Inquiry : 2,395
관리자 23.01.17 2,395
18 Researches on immunomodulatory imides drug development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Int J Mol Sci. (July 31, 2021).
관리자 23.01.17 Inquiry : 2,450
관리자 23.01.17 2,450
17 The therapeutic efficacy results of a candidate immunomodulatory imide drug developed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, ACS P
관리자 23.01.17 Inquiry : 2,483
관리자 23.01.17 2,483
16 Research on the immunomodulatory imide drugs development under the Cooperative Research and Development Agreement(CRADA) with the National Institutes of Health(NIH) have been published in the peer-reviewed publication, Frontiers in Neuroscience(March 2)
관리자 23.01.17 Inquiry : 3,718
관리자 23.01.17 3,718
15 The therapeutic efficacy results of a candidate immunomodulatory imide drug developed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, eLife
관리자 23.01.17 Inquiry : 2,404
관리자 23.01.17 2,404
14 The 6th Target Protein Dissolution Summit
관리자 23.06.22 Inquiry : 2,614
관리자 23.06.22 2,614
13 Patent license agreement with KRICT
관리자 23.05.19 Inquiry : 2,613
관리자 23.05.19 2,613